Company intelligence / Profile preview

CreoSalus

Louisville, Kentucky, United Statescreosalus.com ↗

Ownership: Private
Employees: ~29
Development stage: Commercial

Overview

CreoSalus has manufactured thousands of personalized peptide vaccines for multiple clinical trials with a reported 100% patient order success rate. The company specializes in cGMP contract manufacturing of peptide drug substances and sterile injectable products, supporting both R&D and commercial supply needs.

Therapeutic areas: Oncology
Modalities: PeptidesSmall moleculeBiologic (for sterile injectables and APIs)
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

SucroMate Equine

Commercial

Indications: Ovulation regulation in mares

Beyond the preview

Go deeper on CreoSalus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CreoSalus.

Explore the full profile